Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Watchlist
Price: 4.4 HKD -2.87% Market Closed
Market Cap: 19.9B HKD
Have any thoughts about
Shandong Weigao Group Medical Polymer Co Ltd?
Write Note

Shandong Weigao Group Medical Polymer Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shandong Weigao Group Medical Polymer Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Additional Paid In Capital
ÂĄ2.7B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Additional Paid In Capital
ÂĄ1.3B
CAGR 3-Years
0%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Additional Paid In Capital
ÂĄ4.1B
CAGR 3-Years
0%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Additional Paid In Capital
ÂĄ4.4B
CAGR 3-Years
-1%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Additional Paid In Capital
ÂĄ1.3B
CAGR 3-Years
-6%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Intco Medical Technology Co Ltd
SZSE:300677
Additional Paid In Capital
ÂĄ1.1B
CAGR 3-Years
-9%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Shandong Weigao Group Medical Polymer Co Ltd
Glance View

Market Cap
20.1B HKD
Industry
Health Care

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.

Intrinsic Value
9 HKD
Undervaluation 51%
Intrinsic Value
Price

See Also

What is Shandong Weigao Group Medical Polymer Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
2.7B CNY

Based on the financial report for Jun 30, 2024, Shandong Weigao Group Medical Polymer Co Ltd's Additional Paid In Capital amounts to 2.7B CNY.

What is Shandong Weigao Group Medical Polymer Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
1%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Shandong Weigao Group Medical Polymer Co Ltd have been 2% over the past three years , 1% over the past five years .

Back to Top